Avidity Biosciences, Inc. announced on January 4, 2022, Joseph Baroldi informed the company of his intention to resign as Chief Operating Officer of the Company to pursue a new opportunity. His last day at the Company will be January 21, 2022. The Company has entered into a post-employment consulting agreement with Mr. Baroldi for a term of six months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.96 USD | -4.21% | -1.85% | +186.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+186.85% | 2.48B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Avidity Biosciences, Inc. Announces Resignation of Joseph Baroldi as Chief Operating Officer, Effective January 22, 2022